Irish biotechnology company Elan rejected on Monday the latest takeover bid from US group Royalty Pharma worth about $7.9 billion (6.0 billion euros).

(AP)—Members of the national organization that manages organ transplants are voicing concern about a federal judge's ruling to make two sick children at a Pennsylvania hospital eligible for adult lungs.

British drugmaker AstraZeneca PLC says it is to acquire Pearl Therapeutics Inc., a Redwood-City, California-based company involved in therapies for asthma and chronic obstructive pulmonary disease for at least $560 million.

(Medical Xpress)—Unborn babies 'practise' facial expressions of pain in the womb, according to a study published today.

Carl Simmons regularly used to run 5K races. Now the 76-year-old stroke survivor just wants to be able to keep up with his wife on a walk. Through help from Seattle-based Cadence Biomedical's walking device, Simmons is hopeful.

Shares of Elan Corp. PLC jumped Friday after Royalty Pharma once again raised its offer to buy the Irish drugmaker in an increasingly bitter takeover fight.

You may have read last week that, in a bid to curb graffiti, Sydney's State Rail may trial Mosquito devices – technology that emits a high-pitched noise that's audible only to people aged in their early ...

Irish drugmaker Elan Corp.'s fight against a takeover bid by Royalty Pharma has spilled into U.S. federal court, where a judge has issued a temporary restraining order preventing Royalty from completing its offer to buy the ...

Conjoined Palestinian twins with a shared heart and other vital organs returned home to the West Bank Monday after Israeli doctors determined they could not successfully separate them.

One of the most difficult moments faced by anaesthetists and other healthcare staff is when to carry on attempts to resuscitate a person, and when those efforts should reasonably stop. This dilemma is the subject of a session ...